Skip to content

Health Catalyst HCAT Price / sales

Price / sales at other companies

International Business Machines logo
International Business MachinesIBM
3.3×-0.4×
Oracle logo
OracleORCL
6.5×-1.8×
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
0.5×-0.8×
CareCloud, Inc. logo
CareCloud, Inc.CCLD
1.2×+0.7×
National Research Corporation logo
National Research CorporationNRC
2.8×+0.7×
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
0.1×-0.3×

Other financials

Income statement

See full
Revenue$70.8M-10.9%
Gross profit$35.5M-2.1%
Operating income-$106.5M-428%
Net income-$111.0M-368%
EPS (diluted)-$1.53-337%

Balance sheet

See full
Cash & equivalents$59.9M-82.5%
Total debt$170.6M-57.6%
Total equity$138.1M-63.3%
Total assets$412.2M-53.8%

Cash flow

See full
Operating cash flow$18.5M+6,511%
CapEx$338.0K-49.6%
Free cash flow$18.2M+4,760%

Valuation

See full
Market cap$147.05M-43.6%
Enterprise value$257.76M-32.7%

Profitability

See full
Gross margin49.9%+4.7pp
Operating margin-81.7%-127pp
Net margin-87.7%-138pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-103%-135pp
Debt / equity1.2×+0.2×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Health Catalyst’s reported figures.

Based on the most recent quarter.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Health Catalyst's price / sales?
Health Catalyst (HCAT) reported price / sales of 0.3× in Q1 2026.
How has Health Catalyst's price / sales changed year-over-year?
Health Catalyst's price / sales decreased by 69.8% year-over-year, from 1× to 0.3×.
What is the long-term trend for Health Catalyst's price / sales?
Over 5 years (2020 to 2025), Health Catalyst's price / sales has grown at a -46.2% compound annual growth rate (CAGR), from 12× to 0.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.